This bill amends Pennsylvania's Insurance Company Law to update definitions and provisions related to health insurance coverage. It clarifies how certain government health programs are defined for insurance policies, specifically regarding prescription drug coverage and continuation of coverage for employees who lose their jobs. The legislation also updates the legal definition of a hospital to include facilities operating alcoholism or drug addiction treatment programs and establishes a Long-Term Care Partnership Program to help individuals manage future long-term care costs.
HB 2427 amends Pennsylvania's Insurance Company Law to regulate how insurers cover drugs for stage four, advanced metastatic cancer. The bill prohibits insurance policies from requiring patients to fail a different medication or prove a history of failure before approving coverage for a new drug, provided the drug is FDA-approved and aligns with current clinical best practices. This legislation also repeals the previous Fair Access to Cancer Treatment Law while ensuring that all existing rules, contracts, and decisions made under that law remain in effect.
This Pennsylvania bill designates June 2026 as Aphasia Awareness Month to promote public understanding of aphasia, a language disorder often caused by strokes or brain injuries. The resolution aims to highlight the condition's impact on individuals and their communities while encouraging better diagnosis and treatment. It does not create new laws or funding but serves as a symbolic gesture to raise awareness within the state.
This bill designates June 15, 2026, as 'Elora Joyce Khan Pediatric Brain Cancer Awareness Day' in Pennsylvania to honor a young resident and raise public attention to pediatric brain cancer. The resolution aims to promote education, compassion, and research into the disease while recognizing the Elora J. Khan Foundation's work supporting affected families. It does not change laws or allocate funding but serves as a symbolic gesture to highlight the importance of awareness and advocacy for children battling brain tumors.
HB 1261 bans PFAS chemicals (harmful substances linked to health risks) in firefighting protective gear, requiring safer alternatives for all new equipment. It creates grant programs to help fire companies replace PFAS-containing gear and mandates that state-funded equipment purchases must be PFAS-free. The bill also imposes penalties on entities failing to comply with the PFAS restrictions. These changes directly protect firefighters and guide fire companies' equipment procurement under Pennsylvania law.
HB 2254 adds Chapter 14 to Pennsylvania's Medical Marijuana Act, allowing terminally ill patients to use medical marijuana within specific care facilities (like hospitals, nursing homes, and assisted living residences) under strict conditions. Facilities must create written guidelines within 180 days covering safe storage, patient safety, allowed forms of marijuana, and documentation. The bill imposes a $500 daily civil penalty for noncompliance, with penalties deposited into the Medical Marijuana Program Fund. It does not require facilities to provide certifications, administer marijuana, or permit use in emergency departments. This directly affects terminally ill patients seeking access in regulated care settings and facilities operating under the existing medical marijuana program.
HB 1106 establishes a certification program for chiropractic assistants in Pennsylvania. To become certified, individuals must be at least 18, have a high school diploma, complete an approved training program, pass an exam, and meet background requirements. Certified assistants can only perform tasks delegated by a licensed chiropractor under direct on-premises supervision and must complete 16 hours of continuing education (including 8 in-person hours) every two years to maintain certification. The bill also makes minor editorial changes to the existing Chiropractic Practice Act.
This Pennsylvania House Resolution designates June 2026 as Scleroderma Awareness Month and June 29, 2026, as World Scleroderma Day within the state. The measure aims to increase public understanding of scleroderma, a rare autoimmune condition that causes skin hardening and can affect internal organs, by promoting awareness rather than implementing new policies or funding. The resolution does not change laws or allocate money but serves to highlight the disease and support ongoing research efforts at Pennsylvania universities.
This resolution directs the Joint State Government Commission to study Pennsylvania's disability waiver programs. It specifically examines how to improve experiences for individuals receiving Home and Community-Based Services waivers through the Office of Long-Term Living (OLTL) and Office of Developmental Programs (ODP). The study will assess medical care access, healthcare support barriers, and staffing challenges for waiver participants. The findings will inform future improvements to these services, focusing on people with disabilities who rely on community-based care instead of institutional settings. (HR 134, 2025)
This Pennsylvania House Resolution designates May 2026 as "Amyotrophic Lateral Sclerosis Awareness Month" to highlight the impact of ALS on patients and their families. The bill does not change laws or allocate funding; instead, it serves as a symbolic gesture to increase public understanding of the disease and support ongoing research efforts. By formally recognizing the month, the resolution aims to draw attention to the challenges faced by those living with ALS and the importance of continued medical investigation.
